José Fidel Baizabal-Carvallo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
José Fidel Baizabal-Carvallo has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Marlene Alonso-Juarez
Instituto Politécnico Nacional
22 shared publicationsJoseph Jankovic
Department of Neurology, Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, USA
21 shared publications- Marlene Alonso-Juarez
Instituto Politécnico Nacional, México
7 shared publications Robert Fekete
Department of Neurology, New York Medical College
7 shared publications- Joseph Jankovic
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology Baylor College of Medicine Houston Texas USA
6 shared publications - Robert Fekete
New York Medical College
6 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1866044
Levodopa exacerbated tremor in Parkinson's disease
Background: Levodopa is considered the most effective pharmacological therapy for Parkinson's disease (PD). However, it can cause side effects including diverse types of dyskinesia. In rare cases, tremor worsening has been reported in patients with PD taking levodopa. The frequency of this effect in clinical practice is unclear, and the phenomenology is poorly characterized. Objectives: We aimed to assess the frequency, clinical features, and factors associated with tremor exacerbated by levodopa in patients with PD. Methods: We studied a cohort of 274 consecutive patients with PD and determined the frequency of tremor exacerbated by levodopa. Results: Tremor exacerbation with levodopa was identified in four patients (1.46%) and 1.55% of patients taking levodopa. There were two men and two women, with ages ranging from 53 to 73 years at the time of evaluation. All patients experienced a consistent worsening of rest tremor within 20 min of taking a low dose of levodopa (62.5 mg or 125 mg). No benefit from biperiden or amantadine was observed for levodopa-exacerbated tremor in any of the cases. None of the patients showed signs of atypical parkinsonism or abnormal MRI. Patients with levodopa-exacerbated tremor were very reluctant to take more than a small dose of levodopa or any dose at all, hampering potential benefits for other parkinsonian features such as rigidity, bradykinesia, and parkinsonian gait. Conclusion: Tremor exacerbated by levodopa is an uncommon side effect in patients with PD that limits the benefit of this therapy.
- 12 August 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1866044
Open AccessLevodopa exacerbated tremor in Parkinson's disease
Background: Levodopa is considered the most effective pharmacological therapy for Parkinson's disease (PD). However, it can cause side effects including diverse types of dyskinesia. In rare cases, tremor worsening has been reported in patients with PD taking levodopa. The frequency of this effect in clinical practice is unclear, and the phenomenology is poorly characterized. Objectives: We aimed to assess the frequency, clinical features, and factors associated with tremor exacerbated by levodopa in patients with PD. Methods: We studied a cohort of 274 consecutive patients with PD and determined the frequency of tremor exacerbated by levodopa. Results: Tremor exacerbation with levodopa was identified in four patients (1.46%) and 1.55% of patients taking levodopa. There were two men and two women, with ages ranging from 53 to 73 years at the time of evaluation. All patients experienced a consistent worsening of rest tremor within 20 min of taking a low dose of levodopa (62.5 mg or 125 mg). No benefit from biperiden or amantadine was observed for levodopa-exacerbated tremor in any of the cases. None of the patients showed signs of atypical parkinsonism or abnormal MRI. Patients with levodopa-exacerbated tremor were very reluctant to take more than a small dose of levodopa or any dose at all, hampering potential benefits for other parkinsonian features such as rigidity, bradykinesia, and parkinsonian gait. Conclusion: Tremor exacerbated by levodopa is an uncommon side effect in patients with PD that limits the benefit of this therapy.
- 10 August 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (9) , 522
Tardive blepharospasm
Background Tardive syndromes may present with variable movement disorders. Blepharospasm (BSP), while typically idiopathic in origin, may be drug-induced, but there is little information regarding frequency and phenomenology of tardive BSP. Objectives and Methods We aimed to assess the clinical features of tardive BSP and compare them with patients with idiopathic BSP. The Abnormal Involuntary Movement Scale (AIMS) was used to assess the severity of movements and the Jankovic Rating Scale (JRS) was used to evaluate the severity of BSP. Results Among 72 consecutive patients with tardive syndromes, 15 (20.8%) were identified with BSP. Patients with tardive BSP had a younger age at onset, higher AIMS scores, and a greater frequency of associated akathisia and facial dystonia, compared with patients who had other tardive phenomena (P < 0.05, for all comparisons). Compared with 37 patients with idiopathic BSP, those with a tardive etiology were also younger and had more frequently associated orobuccolingual (OBL) stereotypy, limb/trunk stereotypies, akathisia, and facial dystonia (P ≤ 0.009), whereas apraxia of eyelid opening was only observed in patients with idiopathic BSP. Alleviating maneuvers (sensory tricks) predominated in patients with idiopathic BSP, but this difference did not reach statistical significance (P ≥ 0.05). Furthermore, there was no difference in BSP severity, as assessed by JRS, between the two groups. Comorbid limb/trunk stereotypies and OBL dyskinesia had the greatest diagnostic accuracy supporting tardive origin. Conclusions Tardive BSP, identified in one-fifth of patients with diverse tardive syndromes, has distinct features differing from idiopathic BSP.
- 10 August 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (9) , 522
Tardive blepharospasm
Background Tardive syndromes may present with variable movement disorders. Blepharospasm (BSP), while typically idiopathic in origin, may be drug-induced, but there is little information regarding frequency and phenomenology of tardive BSP. Objectives and Methods We aimed to assess the clinical features of tardive BSP and compare them with patients with idiopathic BSP. The Abnormal Involuntary Movement Scale (AIMS) was used to assess the severity of movements and the Jankovic Rating Scale (JRS) was used to evaluate the severity of BSP. Results Among 72 consecutive patients with tardive syndromes, 15 (20.8%) were identified with BSP. Patients with tardive BSP had a younger age at onset, higher AIMS scores, and a greater frequency of associated akathisia and facial dystonia, compared with patients who had other tardive phenomena (P < 0.05, for all comparisons). Compared with 37 patients with idiopathic BSP, those with a tardive etiology were also younger and had more frequently associated orobuccolingual (OBL) stereotypy, limb/trunk stereotypies, akathisia, and facial dystonia (P ≤ 0.009), whereas apraxia of eyelid opening was only observed in patients with idiopathic BSP. Alleviating maneuvers (sensory tricks) predominated in patients with idiopathic BSP, but this difference did not reach statistical significance (P ≥ 0.05). Furthermore, there was no difference in BSP severity, as assessed by JRS, between the two groups. Comorbid limb/trunk stereotypies and OBL dyskinesia had the greatest diagnostic accuracy supporting tardive origin. Conclusions Tardive BSP, identified in one-fifth of patients with diverse tardive syndromes, has distinct features differing from idiopathic BSP.
- 13 June 2026
- Published by Springer Nature in Journal of Neural Transmission
Tardive cervical dystonia
Tardive cervical dystonia (CD) is a frequent presentation of tardive syndromes, but it has not been extensively studied. We aimed to assess the clinical features of tardive CD and compared them with other tardive phenomena and idiopathic CD. Among 72 consecutive patients with tardive syndromes, CD was identified in 27 (37.5%) cases. Patients with tardive CD were younger and had a more severe clinical presentation with higher AIMS scores (P < 0.001). They also had more frequently associated comorbid facial/trunk dystonia and akathisia (P < 0.005) compared with other patients with tardive phenomena. Furthermore, patients with tardive CD were younger than those with idiopathic CD and had more phasic CD, retrocollis (head extension), facial/trunk dystonia, oro-bucco-lingual dyskinesia, limb chorea/stereotypies, akathisia, and parkinsonism (P < 0.005). No differences were observed in the severity of head deviation in any axis. Sustained CD, torticollis (head rotation), laterocollis (head tilt), alleviating maneuvers, restricted range of head motion, head tremor, and family history of CD were more common in patients with idiopathic CD compared to those with tardive CD (P ≤ 0.001). CD is observed in 37.5% of patients with tardive syndrome. In contrast to idiopathic CD, tardive CD tends to occur in younger individuals with phasic dystonia, retrocollis, and is typically associated with a variety of other hyperkinetic movement disorders.
- 13 June 2026
- Published by Springer Nature in Journal of Neural Transmission
Tardive cervical dystonia
Tardive cervical dystonia (CD) is a frequent presentation of tardive syndromes, but it has not been extensively studied. We aimed to assess the clinical features of tardive CD and compared them with other tardive phenomena and idiopathic CD. Among 72 consecutive patients with tardive syndromes, CD was identified in 27 (37.5%) cases. Patients with tardive CD were younger and had a more severe clinical presentation with higher AIMS scores (P < 0.001). They also had more frequently associated comorbid facial/trunk dystonia and akathisia (P < 0.005) compared with other patients with tardive phenomena. Furthermore, patients with tardive CD were younger than those with idiopathic CD and had more phasic CD, retrocollis (head extension), facial/trunk dystonia, oro-bucco-lingual dyskinesia, limb chorea/stereotypies, akathisia, and parkinsonism (P < 0.005). No differences were observed in the severity of head deviation in any axis. Sustained CD, torticollis (head rotation), laterocollis (head tilt), alleviating maneuvers, restricted range of head motion, head tremor, and family history of CD were more common in patients with idiopathic CD compared to those with tardive CD (P ≤ 0.001). CD is observed in 37.5% of patients with tardive syndrome. In contrast to idiopathic CD, tardive CD tends to occur in younger individuals with phasic dystonia, retrocollis, and is typically associated with a variety of other hyperkinetic movement disorders.
- 27 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (2) , 203
Functional ballistic movements
- 27 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (2) , 203
Functional ballistic movements
- 17 December 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (1) , 31
Functional cervical dystonia: diagnostic accuracy of distinct clinical features
Background Functional dystonia (FD) is one of the most common presentations among patients with functional movement disorders (FMDs). However, FD affecting neck muscles has not been well studied, even though cervical dystonia (CD) is one of the most common movement disorders. Methods We aimed to assess the clinical features and correlations of functional CD. Additionally, we compared the clinical features with 120 consecutive patients with non-functional CD and determined the diagnostic accuracy of contrasting variables. Results We studied 72 consecutive patients with FD (n = 57, 79.2% were females), of whom 34 (47.2%) were identified with functional CD. The latter group had greater severity of FMDs determined by the Simplified Functional Movement Disorders Rating Scale (S-FMDRS) and a more common functional speech disorder compared with patients with FD without CD (P ≤ 0.001, for both variables). Compared to patients with non-functional CD, those with functional CD were younger, had more common retrocollis, anterior head shift, greater severity of dystonic postures, more frequent changing pattern of dystonia, more common dystonia in other body parts, lack of typical alleviating maneuvers (AM) and less frequent neck pain (P < 0.05, for all comparisons). Lack of AM had the highest sensitivity (0.97) and change in dystonia pattern had the highest specificity for the diagnosis of functional CD (0.98). Conclusions Functional CD represented 47.2% of patients with FD. Greater severity of FMDs and comorbid functional speech disorders were more common in patients with functional CD. Several clinical features distinguished functional to non-functional CD.
- 17 December 2025
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (1) , 31
Functional cervical dystonia: diagnostic accuracy of distinct clinical features
Background Functional dystonia (FD) is one of the most common presentations among patients with functional movement disorders (FMDs). However, FD affecting neck muscles has not been well studied, even though cervical dystonia (CD) is one of the most common movement disorders. Methods We aimed to assess the clinical features and correlations of functional CD. Additionally, we compared the clinical features with 120 consecutive patients with non-functional CD and determined the diagnostic accuracy of contrasting variables. Results We studied 72 consecutive patients with FD (n = 57, 79.2% were females), of whom 34 (47.2%) were identified with functional CD. The latter group had greater severity of FMDs determined by the Simplified Functional Movement Disorders Rating Scale (S-FMDRS) and a more common functional speech disorder compared with patients with FD without CD (P ≤ 0.001, for both variables). Compared to patients with non-functional CD, those with functional CD were younger, had more common retrocollis, anterior head shift, greater severity of dystonic postures, more frequent changing pattern of dystonia, more common dystonia in other body parts, lack of typical alleviating maneuvers (AM) and less frequent neck pain (P < 0.05, for all comparisons). Lack of AM had the highest sensitivity (0.97) and change in dystonia pattern had the highest specificity for the diagnosis of functional CD (0.98). Conclusions Functional CD represented 47.2% of patients with FD. Greater severity of FMDs and comorbid functional speech disorders were more common in patients with functional CD. Several clinical features distinguished functional to non-functional CD.
- Open Access
- 12 December 2025
- Published by Elsevier in World Neurosurgery
- Vol. 205, 124719
Early Neurological Deterioration After Recanalization: A Retrospective Study of 1053 Endovascular Treatment Patients
- 12 December 2025
- Published by Elsevier in World Neurosurgery
- Vol. 205, 124719
Open AccessEarly Neurological Deterioration After Recanalization: A Retrospective Study of 1053 Endovascular Treatment Patients
- 22 November 2025
- Published by Springer Nature in The Cerebellum
- Vol. 24 (6) , 180
Response to Critical Appraisal of a Reported Case of DAGLA Associated Cerebellitis
We report a patient with tremor and cerebellar syndrome for whom screening by immunochemistry and later immunoblot confirmation did not disclose other antibodies, except for anti-diacylglycerol lipase alpha (DAGLA). Other etiologies for a cerebellar syndrome were ruled out. Clinical improvement following cancer therapy supports a paraneoplastic origin.
- 22 November 2025
- Published by Springer Nature in The Cerebellum
- Vol. 24 (6) , 180
Response to Critical Appraisal of a Reported Case of DAGLA Associated Cerebellitis
We report a patient with tremor and cerebellar syndrome for whom screening by immunochemistry and later immunoblot confirmation did not disclose other antibodies, except for anti-diacylglycerol lipase alpha (DAGLA). Other etiologies for a cerebellar syndrome were ruled out. Clinical improvement following cancer therapy supports a paraneoplastic origin.
- Open Access
- 22 October 2025
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1664934
Top motor and non-motor complaints in patients with Parkinson's disease
Background: Parkinson's disease (PD) is characterized by several motor and non-motor manifestations. These variable neurological complaints have diverse intensity and cause various degrees of disability. Objective methods: We aimed to assess the top three most troublesome neurological complaints in patients with PD and correlated them with demographic and clinical variables, including the cognitive status assessed by the Montreal Cognitive Assessment (MoCA). Patients were asked about their three most troublesome neurological complaints after reviewing all motor and non-motor symptoms. Responses were divided into three tiers. Results: We studied 230 consecutive patients with PD. There were 130 (56.5%) male patients, with the mean age at evaluation of 67.7 ± 11.06 years. The most common neurological complaints in the top tier were (1) tremor ( n = 80, 34.8%), (2) gait problems ( n = 37, 16.1%), and (3) dyskinesia ( n = 17, 7.4%). Speech difficulties, dyskinesia, and insomnia became more prominent 5 or 10 years after disease onset. A total of 159 (69.1%) patients reported “at least one non-motor symptom” among their top-3 tier complaints. Pain ( n = 29, 12.6%), anxiety ( n = 25, 10.8%), and insomnia ( n = 25, 10.8%) were the most common non-motor symptoms. The presence of non-motor symptoms in the top three tiers was associated with decreased cognitive status (MoCA <25 points), but not with age, sex, or disease evolution time. Cognitive impairment was a significant predictor of non-motor symptoms in their top three tiers [odds ratio [OR]: 3.88 (95% CI: 1.647 to 9.169)]. Cluster analysis of patients with at least one non-motor symptom identified four groups: male or female patients with short evolution time, a postural-instability gait difficulty (PIGD) phenotype, and a dyskinetic group. The latter two were associated with a higher frequency of fatigue, insomnia, pain, and anxiety. Conclusion: Overall, tremor was the most troublesome symptom in patients with PD, though high variability was observed. Approximately 69% of patients had at least one non-motor symptom among their top-3 complaints, which was associated with abnormal cognitive status. Speech difficulties, dyskinesia, and insomnia became more prominent with disease progression. Among patients with non-motor symptoms in the top three tiers, those with a PIGD phenotype or prominent dyskinesia exhibited a higher frequency of fatigue, insomnia, pain, and anxiety, suggesting a clustering effect of non-motor symptoms with these motor presentations.
- 22 October 2025
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1664934
Open AccessTop motor and non-motor complaints in patients with Parkinson's disease
Background: Parkinson's disease (PD) is characterized by several motor and non-motor manifestations. These variable neurological complaints have diverse intensity and cause various degrees of disability. Objective methods: We aimed to assess the top three most troublesome neurological complaints in patients with PD and correlated them with demographic and clinical variables, including the cognitive status assessed by the Montreal Cognitive Assessment (MoCA). Patients were asked about their three most troublesome neurological complaints after reviewing all motor and non-motor symptoms. Responses were divided into three tiers. Results: We studied 230 consecutive patients with PD. There were 130 (56.5%) male patients, with the mean age at evaluation of 67.7 ± 11.06 years. The most common neurological complaints in the top tier were (1) tremor ( n = 80, 34.8%), (2) gait problems ( n = 37, 16.1%), and (3) dyskinesia ( n = 17, 7.4%). Speech difficulties, dyskinesia, and insomnia became more prominent 5 or 10 years after disease onset. A total of 159 (69.1%) patients reported “at least one non-motor symptom” among their top-3 tier complaints. Pain ( n = 29, 12.6%), anxiety ( n = 25, 10.8%), and insomnia ( n = 25, 10.8%) were the most common non-motor symptoms. The presence of non-motor symptoms in the top three tiers was associated with decreased cognitive status (MoCA <25 points), but not with age, sex, or disease evolution time. Cognitive impairment was a significant predictor of non-motor symptoms in their top three tiers [odds ratio [OR]: 3.88 (95% CI: 1.647 to 9.169)]. Cluster analysis of patients with at least one non-motor symptom identified four groups: male or female patients with short evolution time, a postural-instability gait difficulty (PIGD) phenotype, and a dyskinetic group. The latter two were associated with a higher frequency of fatigue, insomnia, pain, and anxiety. Conclusion: Overall, tremor was the most troublesome symptom in patients with PD, though high variability was observed. Approximately 69% of patients had at least one non-motor symptom among their top-3 complaints, which was associated with abnormal cognitive status. Speech difficulties, dyskinesia, and insomnia became more prominent with disease progression. Among patients with non-motor symptoms in the top three tiers, those with a PIGD phenotype or prominent dyskinesia exhibited a higher frequency of fatigue, insomnia, pain, and anxiety, suggesting a clustering effect of non-motor symptoms with these motor presentations.
- Open Access
- 30 June 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (12) , 2289-2295
Functional Head Tremor: Contrasting Features with Other Tremor Etiologies
Background: Functional tremor (FT) is considered the most common phenomenology among patients with functional movement disorders (FMDs). Most patients have limb tremor, but they can also present with tremor involving the head and trunk. Objectives and Methods: We aimed to assess the clinical phenomenology of functional head tremor (FHT) and contrast it with features of HT observed in 125 patients with other tremor etiologies (OTE), including 71 patients with essential tremor (ET). Results: There were 101 consecutive patients (68.3% females) with FT from which n = 36 (35.6%) had FHT. Yes‐yes tremor was the most common directionality (47.2%). Functional trunk tremor was identified in n = 20 (19.8%) patients with FT. Patients with FHT were older ( P < 0.05) and had greater FMDs severity with higher Simplified Functional Movement Disorders Rating Scale (S‐FMDRS) scores ( P < 0.001). When patients with FT were compared with those with OTE and ET, no differences were observed in the proportion of HT, but yes‐yes directionality and more severe HT was more common in those with FMDs. A change in HT directionality was more frequent in patients with functional etiology ( P = 0.007). This sign had high specificity (0.91) but low sensitivity (0.47) for the diagnosis of FHT. Comorbid trunk tremor had specificity of 0.89 and sensitivity of 0.28 to diagnose FHT. Conclusions: HT is present in a third of patients with FT. These patients showed a grater severity of FMDs than FT without HT. A change in tremor directionality and comorbid trunk tremor had high specificity for the diagnosis for FHT compared with OTE.
- 30 June 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (12) , 2289-2295
Open AccessFunctional Head Tremor: Contrasting Features with Other Tremor Etiologies
Background: Functional tremor (FT) is considered the most common phenomenology among patients with functional movement disorders (FMDs). Most patients have limb tremor, but they can also present with tremor involving the head and trunk. Objectives and Methods: We aimed to assess the clinical phenomenology of functional head tremor (FHT) and contrast it with features of HT observed in 125 patients with other tremor etiologies (OTE), including 71 patients with essential tremor (ET). Results: There were 101 consecutive patients (68.3% females) with FT from which n = 36 (35.6%) had FHT. Yes‐yes tremor was the most common directionality (47.2%). Functional trunk tremor was identified in n = 20 (19.8%) patients with FT. Patients with FHT were older ( P < 0.05) and had greater FMDs severity with higher Simplified Functional Movement Disorders Rating Scale (S‐FMDRS) scores ( P < 0.001). When patients with FT were compared with those with OTE and ET, no differences were observed in the proportion of HT, but yes‐yes directionality and more severe HT was more common in those with FMDs. A change in HT directionality was more frequent in patients with functional etiology ( P = 0.007). This sign had high specificity (0.91) but low sensitivity (0.47) for the diagnosis of FHT. Comorbid trunk tremor had specificity of 0.89 and sensitivity of 0.28 to diagnose FHT. Conclusions: HT is present in a third of patients with FT. These patients showed a grater severity of FMDs than FT without HT. A change in tremor directionality and comorbid trunk tremor had high specificity for the diagnosis for FHT compared with OTE.
- 18 June 2025
- Published by Springer Nature in The Cerebellum
- Vol. 24 (4) , 1-3
Tremor and Ataxia in Paraneoplastic Anti-Diacylglycerol Lipase Alpha (DAGLA) Cerebellitis
Antibodies directed against the enzyme diacylglycerol lipase alpha (DAGLA) have been recently discovered to cause a severe autoimmune cerebellar syndrome. We report a patient with DAGLA antibodies with prominent tremor and ataxia occurring in the context of a malignant melanoma, indicating that these antibodies may also occur in paraneoplastic cerebellar degeneration.
- 18 June 2025
- Published by Springer Nature in The Cerebellum
- Vol. 24 (4) , 1-3
Tremor and Ataxia in Paraneoplastic Anti-Diacylglycerol Lipase Alpha (DAGLA) Cerebellitis
Antibodies directed against the enzyme diacylglycerol lipase alpha (DAGLA) have been recently discovered to cause a severe autoimmune cerebellar syndrome. We report a patient with DAGLA antibodies with prominent tremor and ataxia occurring in the context of a malignant melanoma, indicating that these antibodies may also occur in paraneoplastic cerebellar degeneration.